Absorption Study of Topical Phenylephrine in Healthy Women
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests how a topical phenylephrine solution is absorbed through the scalp in healthy women. It aims to understand the drug's safety and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy woman between 18 and 55 years old.
- Your body mass index (BMI) is between 18 and 30, which is a measure of weight relative to height.
- You have a lighter skin type (Fitzpatrick types I to IV) to help ensure consistent absorption of the medicine.
- Your scalp is healthy, with no rashes, irritation, or hair loss.
- You can avoid using any other scalp products during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a product called DA-007 applied to the scalp to help prevent hair loss caused by chemotherapy. It is for people with early-stage breast cancer who are about to start certain types of chemotherapy.
This early-phase study tests how a new scalp product (DA-020) is absorbed through the skin in healthy women. It aims to see how the body processes the medication, which could later help treat conditions like hair loss.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
This Phase 2 trial tests whether using a scalp-cooling device during chemotherapy can help prevent or lessen hair loss in people with metastatic invasive breast cancer. You would need to be starting a specific chemotherapy plan and be willing to begin scalp cooling with your first treatment.
Hear when a new Chemotherapy Induced Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.